|
1
|
Mitroulis I, Alexaki VI, Kourtzelis I,
Ziogas A, Hajishengallis G and Chavakis T: Leukocyte integrins:
Role in leukocyte recruitment and as therapeutic targets in
inflammatory disease. Pharmacol Ther. 147:123–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kansas GS: Selectins and their ligands:
Current concepts and controversies. Blood. 88:3259–3287. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zarbock A and Ley K: Neutrophil adhesion
and activation under flow. Microcirculation. 16:31–42. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiu J and Hogg PJ: Allosteric disulfides:
Sophisticated molecular structures enabling flexible protein
regulation. J Biol Chem. 294:2949–2960. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Edwards BS, Southon EA, Curry MS, Salazar
F, Gale JM, Robinson MK, Graf LH Jr and Born JL: Oxidant inhibition
of alphaLbeta2 integrin adhesion: Evidence for coordinate effects
on conformation and cytoskeleton linkage. J Leukoc Biol.
63:190–202. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schwartz BR and Harlan JM: Sulfhydryl
reducing agents promote neutrophil adherence without increasing
surface expression of CD11b/CD18 (Mac-1, Mo1). Biochem Biophys Res
Commun. 165:51–57. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shimaoka M, Lu C, Palframan RT, von
Andrian UH, McCormack A, Takagi J and Springer TA: Reversibly
locking a protein fold in an active conformation with a disulfide
bond: Integrin alphaL I domains with high affinity and antagonist
activity in vivo. Proc Natl Acad Sci USA. 98:6009–6014. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimaoka M, Lu C, Salas A, Xiao T, Takagi
J and Springer TA: Stabilizing the integrin alpha M inserted domain
in alternative conformations with a range of engineered disulfide
bonds. Proc Natl Acad Sci USA. 99:16737–16741. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hahm E, Li J, Kim K, Huh S, Rogelj S and
Cho J: Extracellular protein disulfide isomerase regulates
ligand-binding activity of αMβ2 integrin and neutrophil recruitment
during vascular inflammation. Blood. 121:3789–3800, S1-S15. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rosenberg N, Mor-Cohen R, Sheptovitsky VH,
Romanenco O, Hess O and Lahav J: Integrin-mediated cell adhesion
requires extracellular disulfide exchange regulated by protein
disulfide isomerase. Exp Cell Res. 381:77–85. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Parakh S and Atkin JD: Novel roles for
protein disulphide isomerase in disease states: A double edged
sword? Front Cell Dev Biol. 3:302015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cai H, Wang CC and Tsou CL: Chaperone-like
activity of protein disulfide isomerase in the refolding of a
protein with no disulfide bonds. J Biol Chem. 269:24550–24552.
1994.PubMed/NCBI
|
|
13
|
McLaughlin SH and Bulleid NJ:
Thiol-independent interaction of protein disulphide isomerase with
type X collagen during intra-cellular folding and assembly. Biochem
J. 331:793–800. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kozlov G, Määttänen P, Thomas DY and
Gehring K: A structural overview of the PDI family of proteins.
FEBS J. 277:3924–3936. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Anelli T, Alessio M, Mezghrani A, Simmen
T, Talamo F, Bachi A and Sitia R: ERp44, a novel endoplasmic
reticulum folding assistant of the thioredoxin family. EMBO J.
21:835–844. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vaux D, Tooze J and Fuller S:
Identification by anti-idiotype antibodies of an intracellular
membrane protein that recognizes a mammalian endoplasmic reticulum
retention signal. Nature. 345:495–502. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho J, Furie BC, Coughlin SR and Furie B:
A critical role for extracellular protein disulfide isomerase
during thrombus formation in mice. J Clin Invest. 118:1123–1131.
2008.PubMed/NCBI
|
|
18
|
Cho J: Protein disulfide isomerase in
thrombosis and vascular inflammation. J Thromb Haemost.
11:2084–2091. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiong B, Jha V, Min JK and Cho J: Protein
disulfide isomerase in cardiovascular disease. Exp Mol Med.
52:390–399. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou J, Wu Y, Wang L, Rauova L, Hayes VM,
Poncz M and Essex DW: The C-terminal CGHC motif of protein
disulfide isomerase supports thrombosis. J Clin Invest.
125:4391–4406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Furie B and Flaumenhaft R: Thiol
isomerases in thrombus formation. Circ Res. 114:1162–1173. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Kim K, Jeong SY, Chiu J, Xiong B,
Petukhov PA, Dai X, Li X, Andrews RK, Du X, et al: Platelet protein
disulfide isomerase promotes glycoprotein Ibalpha-mediated
platelet-neutrophil interactions under thromboinflammatory
conditions. Circulation. 139:1300–1319. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim K, Hahm E, Li J, Holbrook LM,
Sasikumar P, Stanley RG, Ushio-Fukai M, Gibbins JM and Cho J:
Platelet protein disulfide isomerase is required for thrombus
formation but not for hemostasis in mice. Blood. 122:1052–1061.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Flaumenhaft R and Furie B: Vascular thiol
isomerases. Blood. 128:893–901. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Holbrook LM, Watkins NA, Simmonds AD,
Jones CI, Ouwehand WH and Gibbins JM: Platelets release novel thiol
isomerase enzymes which are recruited to the cell surface following
activation. Br J Haematol. 148:627–637. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stopa JD and Zwicker JI: The intersection
of protein disulfide isomerase and cancer associated thrombosis.
Thromb Res. 164 (Suppl 1):S130–S135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Flaumenhaft R, Furie B and Zwicker JI:
Therapeutic implications of protein disulfide isomerase inhibition
in thrombotic disease. Arterioscler Thromb Vasc Biol. 35:16–23.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Z, Zhang H and Cheng Q: PDIA4: The
basic characteristics, functions and its potential connection with
cancer. Biomed Pharmacother. 122:1096882020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou J, Wu Y, Chen F, Wang L, Rauova L,
Hayes VM, Poncz M, Li H, Liu T, Liu J and Essex DW: The disulfide
isomerase ERp72 supports arterial thrombosis in mice. Blood.
130:817–828. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bowley SR, Fang C, Merrill-Skoloff G,
Furie BC and Furie B: Protein disulfide isomerase secretion
following vascular injury initiates a regulatory pathway for
thrombus formation. Nat Commun. 8:141512017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cho J, Kennedy DR, Lin L, Huang M,
Merrill-Skoloff G, Furie BC and Furie B: Protein disulfide
isomerase capture during thrombus formation in vivo depends on the
presence of β3 integrins. Blood. 120:647–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jasuja R, Furie B and Furie BC:
Endothelium-derived but not platelet-derived protein disulfide
isomerase is required for thrombus formation in vivo. Blood.
116:4665–4674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Diamond MS, Staunton DE, de Fougerolles
AR, Stacker SA, Garcia-Aguilar J, Hibbs ML and Springer TA: ICAM-1
(CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol.
111:3129–3139. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ivetic A, Hoskins Green HL and Hart SJ:
L-selectin: A major regulator of leukocyte adhesion, migration and
signaling. Front Immunol. 10:10682019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zerria K, Jerbi E, Hammami S, Maaroufi A,
Boubaker S, Xiong JP, Arnaout MA and Fathallah DM: Recombinant
integrin CD11b A-domain blocks polymorphonuclear cells recruitment
and protects against skeletal muscle inflammatory injury in the
rat. Immunology. 119:431–440. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vojtek AB and Hollenberg SM: Ras-Raf
interaction: Two-hybrid analysis. Methods Enzymol. 255:331–342.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bartel PL and Fields S: Analyzing
protein-protein interactions using two-hybrid system. Methods
Enzymol. 254:241–263. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fromont-Racine M, Rain JC and Legrain P:
Toward a functional analysis of the yeast genome through exhaustive
two-hybrid screens. Nat Genet. 16:277–282. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Formstecher E, Aresta S, Collura V,
Hamburger A, Meil A, Trehin A, Reverdy C, Betin V, Maire S, Brun C,
et al: Protein interaction mapping: A Drosophila case study. Genome
Res. 15:376–384. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu ZQ, Mahmood T and Yang PC: Western
blot: Technique, theory and trouble shooting. N Am J Med Sci.
6:1602014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ilié M, Beaulande M, Ben Hadj S, Chamorey
E, Schiappa R, Long-Mira E, Lassalle S, Butori C, Cohen C, Leroy S,
et al: Chromogenic multiplex immunohistochemistry reveals
modulation of the immune microenvironment associated with survival
in elderly patients with lung adenocarcinoma. Cancers. 10:3262018.
View Article : Google Scholar
|
|
43
|
Dixon AR, Bathany C, Tsuei M, White J,
Barald KF and Takayama S: Recent developments in multiplexing
techniques for immunohistochemistry. Expert Rev Mol Diagn.
15:1171–1186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nuzzi PA, Lokuta MA and Huttenlocher A:
Analysis of neutrophil chemotaxis. Methods Mol Biol. 370:23–36.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kilgore KS, Ward PA and Warren JS:
Neutrophil adhesion to human endothelial cells is induced by the
membrane attack complex: The roles of P-selectin and platelet
activating factor. Inflammation. 22:583–598. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Granger DN and Senchenkova E: Inflammation
and The Microcirculation. Morgan & Claypool Life Sciences; San
Rafael, CA: 2010, View Article : Google Scholar
|
|
47
|
Issekutz AC and Issekutz TB: The
contribution of LFA-1 (CD11a/CD18) and MAC-1 (CD11b/CD18) to the in
vivo migration of polymorphonuclear leucocytes to inflammatory
reactions in the rat. Immunology. 76:655–661. 1992.PubMed/NCBI
|
|
48
|
Issekutz TB: Leukocyte adhesion and the
anti-inflammatory effects of leukocyte integrin blockade. Agents
Actions Suppl. 46:85–96. 1995.PubMed/NCBI
|
|
49
|
Meunier L, Usherwood YK, Chung KT and
Hendershot LM: A subset of chaperones and folding enzymes form
multiprotein complexes in endoplasmic reticulum to bind nascent
proteins. Mol Biol Cell. 13:4456–4469. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Londhe P and Guttridge DC: Inflammation
induced loss of skeletal muscle. Bone. 80:131–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Passam FH, Lin L, Gopal S, Stopa JD,
Bellido-Martin L, Huang M, Furie BC and Furie B: Both platelet- and
endothelial cell-derived ERp5 support thrombus formation in a
laser-induced mouse model of thrombosis. Blood. 125:2276–2285.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bennett TA, Edwards BS, Sklar LA and
Rogelj S: Sulfhydryl regulation of L-selectin shedding:
Phenylarsine oxide promotes activation-independent L-selectin
shedding from leukocytes. J Immunol. 164:4120–4129. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Franscini N, Bachli EB, Blau N, Leikauf
MS, Schaffner A and Schoedon G: Gene expression profiling of
inflamed human endothelial cells and influence of activated protein
C. Circulation. 110:2903–2909. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rao RM, Yang L, Garcia-Cardena G and
Luscinskas FW: Endothelial-dependent mechanisms of leukocyte
recruitment to the vascular wall. Circ Res. 101:234–247. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sidney LE, Branch MJ, Dunphy SE, Dua HS
and Hopkinson A: Concise review: Evidence for CD34 as a common
marker for diverse progenitors. Stem Cells. 32:1380–1389. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mor-Cohen R, Rosenberg N, Einav Y, Zelzion
E, Landau M, Mansour W, Averbukh Y and Seligsohn U: Unique
disulfide bonds in epidermal growth factor (EGF) domains of β3
affect structure and function of αIIbβ3 and αvβ3 integrins in
different manner. J Biol Chem. 287:8879–8891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Mor-Cohen R, Rosenberg N, Landau M, Lahav
J and Seligsohn U: Specific cysteines in beta3 are involved in
disulfide bond exchange-dependent and -independent activation of
alphaIIbbeta3. J Biol Chem. 283:19235–19244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yan B and Smith JW: Mechanism of integrin
activation by disulfide bond reduction. Biochemistry. 40:8861–8867.
2001. View Article : Google Scholar : PubMed/NCBI
|
